EXOZYMES INC.

EXOZ · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 32 employees
35
SEC Filings
$4.11
Close 2026-10-29
32
Employees

Business Summary

eXoZymes Inc. (formerly Invizyne Technologies, Inc.) develops AI-engineered enzymes called 'exozymes' that function outside living cells in bioreactors to convert feedstocks into valuable chemicals. The company targets nutraceuticals, active pharmaceutical ingredients (APIs), and biofuels such as isobutanol for Sustainable Aviation Fuel. It has received over $17.6 million in grants from DOE, NIH, Gates Foundation, and Shell GCxN to advance its cell-free biomanufacturing platform.

Latest Stock Quote

EXOZ 2026-10-29 $4.11 O:$4.3 H:$4.31 L:$4 Vol:0.0M VWAP:$4.138
origin leaf: null

Next Earnings

expected 2026-12-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001493152-26-013563EDGAR54K words
2025-03-312024-12-310001641172-25-001744EDGAR51K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-132026-09-300001493152-26-051689EDGAR24K words
2026-08-132026-06-300001493152-26-037725EDGAR21K words
2025-11-132025-09-300001493152-25-022289EDGAR20K words
2025-08-122025-06-300001641172-25-023184EDGAR19K words
2025-05-122025-03-310001641172-25-009636EDGAR16K words
2024-11-122024-09-300001493152-24-044813EDGAR18K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-090001493152-26-046456EDGAR0K words
2026-09-180001493152-26-043288EDGAR1K words
2026-03-310001493152-26-013733EDGAR0K words
2026-02-050001493152-26-005176EDGAR1K words
2025-12-120001493152-25-027327EDGAR1K words
2025-11-130001493152-25-022295EDGAR0K words
2025-10-030001493152-25-016831EDGAR0K words
2025-07-280001641172-25-021084EDGAR1K words
2025-07-080001641172-25-018053EDGAR0K words
2025-06-260001641172-25-016681EDGAR1K words

35 total filings indexed. 17 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

nutraceuticals pharmaceuticals-/-active-pharmaceutical-ingredients sustainable-aviation-fuel-/-biofuels industrial-chemicals

Company Identity

CIK0002010788
TickerEXOZ
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV
Websitehttps://www.exozymes.com
Listed2024-11-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: e6aff2f346c7f8a0b736df85e7dd9419ded83154e566778f566861b34c75f625
parent: a8476e36a7255d20d9dc4ed61bec0e169ed3e1cd827e870ca8e171c9720f49ef
content hash: 0b094afaa4ee867fc8694671c7c715d1e1c6548cbf273ca34f76c26df1c4f719
signed: 2026-11-16T19:02:00.996Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up EXOZ using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on EXOZ, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/EXOZ (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.